Job Title: Chief Scientific Officer(CSO)

Responsibilities:

Develop medium- and long-term R&D plans according to the company’s development strategies, and determine the basic research direction for the company’s products;

Undertake and provide assistance to the launch of antibody projects as well as research of related targets, pathways and treatment mechanisms;

Undertake new drug R&D tasks in tumor immunotherapy and therapeutic antibodies, conduct theoretical and experimental validation of new drug targets, and develop, organize, and implement related R&D plans;

Guide and foster an exceptional scientific research team, discover and explore new mechanisms of diseases, and come up with new technical methods for problem solving;

Support late phase processes, clinical research, and industrialization;

Establish collaborations with external scientific research institutions and experts, and achieve R&D targets through reasonable utilization of internal and external resources.

Qualifications:

PhD or postdoc in immunology, oncology, biology, medicine or other related fields;

Over 10 years of experience in immunology, tumor immunology and antibody drug-related research as well as extensive experience in tumor immunity and cellular immunity;

Familiar with the fundamentals and current progress in tumor immunology and able to independently design complex experiments related to immunology;

Familiar with translational medicine, current drug targets and pathways; have a thorough understanding of tumor immunotherapy;

Competent in project management, organization and team collaboration;

Passionate about the development of new drugs, and experience in bispecific antibody drug research is preferred;

Excellent communication and leadership skills.

If you are interested in this position, please send your resume to us!

Beijing:renshanghe@sumgenbio.com   +86-10-56315401-808 Ms. Ren

Hangzhou/Shanghai:hr@sumgenbio.com  +86-571-86837379 Ms. Zhao

Copyright Rm. 301, F3, Building C, Block 2, No. 688, Bin'an Road, Changhe Zhejiang ICP Filing No. 18039044